Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES10.4399661016110.8920
Domestic EquitiesEQ - CIPLA LTD.5.519540000058.6280
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.4.664639600049.5475
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD4.34458028346.1467
Domestic EquitiesEQ - AJANTA PHARMA LTD.4.085317282943.3939
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.775827525040.1067
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.64505627138.7173
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.3.48595600037.0272
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.092046500032.8430
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD3.044720445132.3401
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD2.951021399231.3455
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE2.772343035029.4467
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.701525000028.6950
Domestic EquitiesEQ - GLAND PHARMA LTD.2.692118000028.5948
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD2.669125196828.3514
Domestic EquitiesEQ - COHANCE LIFESCIENCES LIMITED2.648426850728.1315
Domestic EquitiesEQ - LUPIN LTD.2.580314000027.4078
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.526012464426.8309
Domestic EquitiesEQ - IPCA LABORATORIES LTD.2.060715362821.8889
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD2.030838567521.5708
Domestic EquitiesEQ - ALKEM LABORATORIES LTD1.92004000020.3940
Domestic EquitiesEQ - ZYDUS LIFESCIENCES LTD1.907721789020.2638
Domestic EquitiesEQ- GLOBAL HEALTH LTD.1.731015474718.3870
Domestic EquitiesEQ - PFIZER LIMITED1.63903101517.4096
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.638966590717.4081
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD1.581710000016.8010
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.573487114516.7120
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.298815121513.7961
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.1.28034283513.5988
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.260414000013.3882
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD1.18012379212.5351
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.095618000011.6379
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS1.065011111311.3119
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.99108967510.5261
Domestic EquitiesEQ - AMI ORGANICS LTD0.98818922410.4954
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD0.8764700009.3093
Domestic EquitiesEQ - LAXMI DENTAL LIMITED0.85122356079.0414
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD0.7666580588.1426
Domestic EquitiesEQ - SAI LIFE SCIENCES LTD0.71521003587.5966
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.71031200007.5450
Domestic EquitiesEQ - CONCORD BIOTECH LTD0.5296321715.6251
Total 97.3300 1033.8307
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS2.6597 28.2510
Total 2.6597 28.2510
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.010400.1100
Total 0.0104 0.1100
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.